Cholinesterase inhibitors in late-stage Alzheimer's disease

被引：6

作者：

Gauthier, S ^{[1
]}

机构：

[1] McGill Ctr Studies Aging, Montreal, PQ, Canada

来源：

LANCET NEUROLOGY | 2006年 / 5卷 / 06期

关键词：

D O I：

10.1016/S1474-4422(06)70454-9

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：468 / 469

页数：2

共 6 条

[1]

Cummings Jeffrey L, 2005, Am J Geriatr Pharmacother, V3, P137, DOI 10.1016/S1543-5946(05)80020-0

[2] Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial [J].

Feldman, H ;

Gauthier, S ;

Hecker, J ;

Vellas, B ;

Xu, YK ;

Ieni, JR ;

Schwam, EM .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (06) :559-569

[3] Effects of memantine on behavioural symptoms in Alzheimer's disease patients:: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies [J].

Gauthier, S ;

Wirth, Y ;

Möbius, HJ .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (05) :459-464

[4] Donepezil for severe Alzheimers disease [J].

Hogan, DB .

LANCET, 2006, 367 (9516) :1031-1032

[5]

ROCKWOOD K, 2006, CMAJ, V174, P1117

[6] Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study [J].

Winblad, B ;

Kilander, L ;

Eriksson, S ;

Minthon, L ;

Båtsman, S ;

Wetterholm, AL ;

Jarisson-Blixt, C ;

Hoglund, A .

LANCET, 2006, 367 (9516) :1057-1065

← 1 →